ABOUT 
SPECIALTY CARE
Abbott, a major manufacturer of FreeStyle continuous glucose monitoring (CGM) technology, will host and lead a series of 30-minute online training webinars in February and March 2022 for participating MCT2D members. Sessions are completely optional and are not hosted or associated with the Michigan Collaborative for Type 2 Diabetes (MCT2D).
Speakers include:
Susanna Robinson, PharmD, CDCES - East Region Medical Science Liaison Manager
Teresa Ditmer, ACNS-BC, BC-ADM - Great Lakes Medical Science Liaison
Alex Khouz, PharmD - Northeast Medical Science Liaison
Stephen Wills, PA-C - Pacific Northwest Medical Science Liaison
TRAINING LINE-UP
Tuesday, February 1, 2022 - 12:30 - 1PM EST
Welcome to FreeStyle Libre – Introduction to CGM & the FreeStyle Libre family of products
Tuesday, February 8, 2022 - 12:30 - 1PM EST
Getting Started with FreeStyle Libre - tips and guidance on application and use of the FreeStyle Libre Family of Systems.
Tuesday, February 15, 2022 - 12:30 - 1PM EST
This or That - Guide to the FreeStyle Libre Readers and Mobile Applications
Tuesday, February 22, 2022 - 12:30 - 1PM EST
Different and Accurate – Accuracy and Performance of the FreeStyle Libre Family
Tuesday, March 1, 2022 - 12:30 - 1PM EST
Getting Started with LibreView – Set up and utilization of LibreView
Tuesday, March 8, 2022 - 12:30 - 1PM EST
Let’s Take a Tour of LibreView – Clinical interpretation of AGP Report
Tuesday, March 15, 2022 - 12:30 - 1PM EST
Let’s Take a Tour of LibreView – Clinical Interpretation of additional reports.
Tuesday, March 22, 2022 - 12:30 - 1PM EST
Real World Performance of FreeStyle Libre – Review of real-world outcomes associated with the use of FreeStyle Libre
Register in advance for this meeting:
Tuesday, March 29, 2022 - 12:30 - 1PM EST
Empowering All – Guide to Educational Resources for patients and provider.
Register in advance for this meeting:
Subscribe to the MCT2D Newsletter
Once per month we deliver news, updates, events, and more directly to you!
ccteam@mct2d.org
Support for The Michigan Collaborative for Type 2 Diabetes (MCT2D) is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program.
Although Blue Cross Blue Shield of Michigan and MCT2D work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs and viewpoints of BCBSM or any of its employees.